Ley et al. confirmed that mutations in CEBPA and other myeloid transcription factor genes, such as DNMT3A, NPM1, IDH1/2 and RUNX1, were common in AML and suggested that these mutations had functions related to the pathogenesis of AML [31]. This evidence concerns the gene NPM1 and acute myeloid leukemia.